AMILI raises $10.5m in over-subscribed Series A round led by Vulcan Capital
AMILI, a Singapore-based precision gut microbiome company, has raised $10.5 million in a Series A funding led by Vulcan Capital, the investment arm of the late Microsoft Corp co-founder Paul Allen. Other new investors include Pruksa Group, TVM Capital Healthcare, Emtek Group, Capital Code, Pureland Group, Blue7 and SEEDS Capital,